Johnson & Johnson, the
family-owned company founded over a century ago, is once again showing its ability
to weather the tough times and maintain its position as a deeply trusted brand.
Driven by sales of several new drugs, it posted a 13 percent increase in profit
in Q2 and has increased its profit forecast twice since January.
Despite intense generic
competition and product recalls, Johnson & Johnson's commitment to its core
value (putting the care of others first), and its efforts to increase both presence
and consumer understanding, are all contributing to a stronger brand. The "Champions of
launched in conjunction with Johnson & Johnson's 2014 FIFA World Cup
sponsorship, has also given the brand a boost. This initiative celebrates
people who go above and beyond to care for others and Johnson & Johnson
clearly hopes it will inspire consumers to create a more caring world.
Bouncing back from the 2010 product
several top-selling non-prescription medicines, Johnson
& Johnson is increasing relevance and regaining brand loyalty by returning
products to shelves. This year, 75 percent of the over-the-counter products that
were scheduled for reintroduction in the U.S. were returned to shelves. With innovation centers opening up in five locations
worldwide, Johnson & Johnson will increase its capability to produce
products that are relevant, responsive to market changes, and in line with
By staying true to its
long-standing mission, and by also pursuing equity-building innovation and
expansion, Johnson & Johnson is on track to securing its future as a brand
that consumers can continue to trust.